These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1815430)

  • 1. Clonidine for growth acceleration.
    Toy C; Middleton RK
    DICP; 1991 Dec; 25(12):1339-40. PubMed ID: 1815430
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of knemometry as a method for control of growth in short-stature children during a single-year treatment with growth hormone].
    Mortensen HB; Main KM; Michaelsen KF; Kastrup KW; Jørgensen JT; Skakkebaek NE
    Ugeskr Laeger; 1993 Apr; 155(15):1135-9. PubMed ID: 8488601
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay.
    Castro-Magaña M; Angulo M; Fuentes B; Castelar ME; Cañas A; Espinoza B
    J Pediatr; 1986 Nov; 109(5):784-7. PubMed ID: 3095519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pretreatment growth rate and response to therapy with growth hormone (HGH)].
    Cianfarani S; Spadoni GL; Scirè G; Manca Bitti ML; Galasso C; Benvenuti S; Rezza E; Boscherini B
    Minerva Pediatr; 1987 Oct; 39(19):757-61. PubMed ID: 3325798
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of growth disorders in children.
    Cuttler L
    Pediatrician; 1987; 14(3):109-20. PubMed ID: 3134649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.
    Haddy TB; Mosher RB; Nunez SB; Reaman GH
    Pediatr Blood Cancer; 2006 Feb; 46(2):258-61. PubMed ID: 16369923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current developments in the treatment of growth delay using growth hormone].
    Wit JM
    Tijdschr Kindergeneeskd; 1986 Dec; 54(6):170-6. PubMed ID: 3103256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body height in children with growth hormone deficiency: results following 5-l5 years of treatment].
    Tanner JM
    Z Gesamte Inn Med; 1988 Aug; 43(15):408-11. PubMed ID: 3176581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone provocation tests and their prediction in the growth of children treated for acute lymphoblastic leukemia.
    Papadia C; Naves LA; Motta LD; Barboza Filho RF; Suzuki MT; Casulari LA
    Minerva Endocrinol; 2006 Sep; 31(3):211-8. PubMed ID: 17213788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment with biosynthetic growth hormone (GH) of familial short stature].
    Farello G; De Simone M; Gentile T; De Matteis F
    Minerva Pediatr; 1994; 46(7-8):347-50. PubMed ID: 7935253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities to increase the efficacy of growth hormone therapy in Turner syndrome].
    Ságodi L; Sólyom E
    Orv Hetil; 1997 Jun; 138(23):1501-5. PubMed ID: 9254366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity in children. Review of several aspects].
    Pombo M; Cabo P; Pina R; Marqués J; Tojo R
    An Esp Pediatr; 1989 Sep; 31(3):307-16. PubMed ID: 2517188
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonidine therapy for short stature: can the question be put to rest?
    Usala AL; Reed MD
    DICP; 1991 Dec; 25(12):1384-5. PubMed ID: 1815438
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs. children with short stature.
    Leckman JF; Cohen DJ; Gertner JM; Ort S; Harcherik DF
    J Am Acad Child Psychiatry; 1984 Mar; 23(2):174-81. PubMed ID: 6585418
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth hormone-releasing hormone: clinical aspects.
    Moreno Esteban B; Garrido M; Rejas J; Lorenzo L; Rodriguez P; Tresguerres JA
    J Pediatr Endocrinol; 1993; 6(3-4):311-6. PubMed ID: 7920999
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose oral clonidine: effective growth hormone releasing agent in children but not in adolescents.
    Batista MC; Arnhold IJ; Mendonça BB; D'Abronzo FH; Bloise W; Nicolau W
    J Pediatr; 1987 Oct; 111(4):564-7. PubMed ID: 3309234
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial growth hormone releasing factor deficiency in pseudopseudohypoparathyroidism.
    Stirling HF; Barr DG; Kelnar CJ
    Arch Dis Child; 1991 Apr; 66(4):533-5. PubMed ID: 2031618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine: an effective growth hormone-releasing agent.
    J Pediatr; 1983 Mar; 102(3):484-5. PubMed ID: 6827430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.